Abbisko taps Hong Kong IPO market for $225m

Biopharmaceutical firm Abbisko kicked off bookbuilding for its Hong Kong IPO on Thursday, aiming to raise HK$1.75bn ($225.2m). The Shanghai-based company specialises in the discovery and development ... ( read original story ...)